Generics in South Korea
Generics in South Korea
SUMMARY
Generics in South Korea industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Generics in South Korea industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The South Korean generics market had total revenues of $5.1bn in 2018, representing a compound annual growth rate (CAGR) of 7.8% between 2014 and 2018.
- Market consumption volume increased with a CAGR of 3.1% between 2014 and 2018, to reach 73.2% of total pharma volume.
- Generics are becoming more and more popular in South Korea as the government realizes the cost saving potential.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in South Korea
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in South Korea
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the South Korea generics market with five year forecasts by both value and volume
- What was the size of the South Korea generics market by value in 2018?
- What will be the size of the South Korea generics market in 2023?
- What factors are affecting the strength of competition in the South Korea generics market?
- How has the market performed over the last five years?
- How large is South Korea’s generics market in relation to its regional counterparts?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. Which players have been most successful in the recent past (1-3 years)?
8 COMPANY PROFILES
8.1. Pfizer Inc.
8.2. Teva Pharmaceutical Industries Limited
8.3. Mylan N.V.
8.4. Yuhan Corp
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. Which players have been most successful in the recent past (1-3 years)?
8 COMPANY PROFILES
8.1. Pfizer Inc.
8.2. Teva Pharmaceutical Industries Limited
8.3. Mylan N.V.
8.4. Yuhan Corp
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: South Korea generics market value: $ million, 2014-18
Table 2: South Korea generics market volume: % of total pharma, 2014-18
Table 3: South Korea generics market geography segmentation: $ million, 2018
Table 4: South Korea generics market value forecast: $ million, 2018-23
Table 5: South Korea generics market volume forecast: % of total pharma, 2018-23
Table 6: Pfizer Inc.: key facts
Table 7: Pfizer Inc.: Annual Financial Ratios
Table 8: Pfizer Inc.: Key Employees
Table 9: Pfizer Inc.: Key Employees Continued
Table 10: Teva Pharmaceutical Industries Limited: key facts
Table 11: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 12: Teva Pharmaceutical Industries Limited: Key Employees
Table 13: Mylan N.V.: key facts
Table 14: Mylan N.V.: Annual Financial Ratios
Table 15: Mylan N.V.: Key Employees
Table 16: Yuhan Corp: key facts
Table 17: Yuhan Corp: Annual Financial Ratios
Table 18: Yuhan Corp: Key Employees
Table 19: South Korea size of population (million), 2014-18
Table 20: South Korea gdp (constant 2005 prices, $ billion), 2014-18
Table 21: South Korea gdp (current prices, $ billion), 2014-18
Table 22: South Korea inflation, 2014-18
Table 23: South Korea consumer price index (absolute), 2014-18
Table 24: South Korea exchange rate, 2014-18
Table 1: South Korea generics market value: $ million, 2014-18
Table 2: South Korea generics market volume: % of total pharma, 2014-18
Table 3: South Korea generics market geography segmentation: $ million, 2018
Table 4: South Korea generics market value forecast: $ million, 2018-23
Table 5: South Korea generics market volume forecast: % of total pharma, 2018-23
Table 6: Pfizer Inc.: key facts
Table 7: Pfizer Inc.: Annual Financial Ratios
Table 8: Pfizer Inc.: Key Employees
Table 9: Pfizer Inc.: Key Employees Continued
Table 10: Teva Pharmaceutical Industries Limited: key facts
Table 11: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 12: Teva Pharmaceutical Industries Limited: Key Employees
Table 13: Mylan N.V.: key facts
Table 14: Mylan N.V.: Annual Financial Ratios
Table 15: Mylan N.V.: Key Employees
Table 16: Yuhan Corp: key facts
Table 17: Yuhan Corp: Annual Financial Ratios
Table 18: Yuhan Corp: Key Employees
Table 19: South Korea size of population (million), 2014-18
Table 20: South Korea gdp (constant 2005 prices, $ billion), 2014-18
Table 21: South Korea gdp (current prices, $ billion), 2014-18
Table 22: South Korea inflation, 2014-18
Table 23: South Korea consumer price index (absolute), 2014-18
Table 24: South Korea exchange rate, 2014-18
LIST OF FIGURES
Figure 1: South Korea generics market value: $ million, 2014-18
Figure 2: South Korea generics market volume: % of total pharma, 2014-18
Figure 3: South Korea generics market geography segmentation: % share, by value, 2018
Figure 4: South Korea generics market value forecast: $ million, 2018-23
Figure 5: South Korea generics market volume forecast: % of total pharma, 2018-23
Figure 6: Forces driving competition in the generics market in South Korea, 2018
Figure 7: Drivers of buyer power in the generics market in South Korea, 2018
Figure 8: Drivers of supplier power in the generics market in South Korea, 2018
Figure 9: Factors influencing the likelihood of new entrants in the generics market in South Korea, 2018
Figure 10: Factors influencing the threat of substitutes in the generics market in South Korea, 2018
Figure 11: Drivers of degree of rivalry in the generics market in South Korea, 2018
COMPANIES MENTIONED
Pfizer Inc.
Teva Pharmaceutical Industries Limited
Mylan N.V.
Yuhan Corp
Figure 1: South Korea generics market value: $ million, 2014-18
Figure 2: South Korea generics market volume: % of total pharma, 2014-18
Figure 3: South Korea generics market geography segmentation: % share, by value, 2018
Figure 4: South Korea generics market value forecast: $ million, 2018-23
Figure 5: South Korea generics market volume forecast: % of total pharma, 2018-23
Figure 6: Forces driving competition in the generics market in South Korea, 2018
Figure 7: Drivers of buyer power in the generics market in South Korea, 2018
Figure 8: Drivers of supplier power in the generics market in South Korea, 2018
Figure 9: Factors influencing the likelihood of new entrants in the generics market in South Korea, 2018
Figure 10: Factors influencing the threat of substitutes in the generics market in South Korea, 2018
Figure 11: Drivers of degree of rivalry in the generics market in South Korea, 2018
COMPANIES MENTIONED
Pfizer Inc.
Teva Pharmaceutical Industries Limited
Mylan N.V.
Yuhan Corp